Rapport Therapeutics RAPP
NASDAQ RAPP
$26.49 +1.43 (+5.71%)
As of: Oct 22, 2026 · 3:30 PM EDT

Rapport Therapeutics (RAPP) Change in Other Operating Liabilities (2023 - 2026)

Updated

Analysis

Rapport Therapeutics (RAPP) Change in Other Operating Liabilities (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,169.70 Bn 1,138.29 Bn 19.71 Bn -
2 Johnson & Johnson 647.50 Bn 567.36 Bn 17.30 Bn 2.69 Bn
3 AbbVie 504.26 Bn 477.37 Bn 12.70 Bn -
4 Merck 368.38 Bn 322.75 Bn 12.21 Bn -
5 Novartis Ag 303.14 Bn 267.13 Bn 11.24 Bn -
6 Astrazeneca 268.24 Bn 241.93 Bn 12.86 Bn -
7 Amgen 242.50 Bn 197.90 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -
9 Pfizer 173.14 Bn 119.78 Bn 10.94 Bn -112.00 Mn
10 Rapport Therapeutics 1.25 Bn 432.73 Mn - 698,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 698,000.00
Mar 31, 2026 681,000.00
Dec 31, 2025 389,000.00
Sep 30, 2025 -9,000.00
Jun 30, 2025 38,000.00
Mar 31, 2025 73,000.00
Dec 31, 2024 175,000.00
Sep 30, 2024 169,000.00
Jun 30, 2024 165,000.00
Mar 31, 2024 161,000.00
Dec 31, 2023 158,000.00
API Access

Rapport Therapeutics Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=RAPP&period=max&api_key=YOUR_API_KEY